SavedAdd your journal

Journals / Journal of Experimental and Clinical Medicine / 2022 / Cilt: 39 - Sayı: 3

EVALUATION OF OVARIAN RESERVE IN LATE REPRODUCTIVE AGE

Deniz KULAKSIZ
Recep ERİN
Pages
719–722
Publication Date
2022-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

AMH, ovarian volume and ovarian weight, and AFC can show us the ovarian reserve with the highest reliability in women of late reproductive age.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), antimullerian hormone (AMH), and ovarian volume are commonly used to assess ovarian reserve and ovarian response to stimulation, no test directly indicates this.
📊
Key Findings & Data:It was aimed to observe how ovarian reserve tests help us in diagnosis and treatment for women of late reproductive age. 190 patients were included in this prospective cohort study.
💡
Conclusion & Impact:AMH, ovarian volume and ovarian weight, and AFC can show us the ovarian reserve with the highest reliability in women of late reproductive age.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antimüllerian hormone · antral follicle · infertility

Abstract

Although follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), antimullerian hormone (AMH), and ovarian volume are commonly used to assess ovarian reserve and ovarian response to stimulation, no test directly indicates this. It was aimed to observe how ovarian reserve tests help us in diagnosis and treatment for women of late reproductive age. 190 patients were included in this prospective cohort study. FSH, LH, E2 and AMH blood samples were taken on the third day of menstruation to biochemically evaluate the ovarian reserve in 190 patients who were planned for hysterectomy and bilateral salpingoopherectomy at late reproductive age, and antral follicle count (AFC) and ovarian volume were recorded by transvaginal ultrasonography for ultrasonographic evaluation. Ovarian weight was weighed postoperatively. When the data of 190 women aged 39-44.9 years are analyzed, AMH and ovarian volume, ovarian volume and AFS show significant positive correlations. FSH, LH and E2 levels do not show a significant relationship with AFS. AMH, ovarian volume and ovarian weight, and AFC can show us the ovarian reserve with the highest reliability in women of late reproductive age.

🔖

Cite This Article

KULAKSIZ, D., ERİN, R. (2022). EVALUATION OF OVARIAN RESERVE IN LATE REPRODUCTIVE AGE. Journal of Experimental and Clinical Medicine, Cilt: 39 - Sayı: 3, 719–722. https://ajindex.com/articles/677644

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Josso N, Legeai L, Forest MG, Enfants-malades H, Cedex P, Recherches U De, et al. An Enzyme Linked Immunoassay for Anti-Miillerian Hormone: A New Tool for the Evaluation of Testicular Function in Infants and Children. 2015;70(1):23–7
  2. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82(5):1323–9
  3. Durlinger ALL, Gruijters MJG, Kramer P, Karels BAS, Ingraham HA, Nachtigal MW, et al. ¨ llerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary. 2014;143(October):1076–84
  4. Melado L, Lawrenz B, Sibal J, Abu E, Coughlan C, Navarro AT, et al. Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay. Front Endocrinol (Lausanne) [Internet]. 2018 Nov 27;9
  5. Ulrich ND, Marsh EE. Ovarian Reserve Testing: A Review of the Options, Their Applications, and Their Limitations. Clin Obstet Gynecol. 2019;62(2):228–37
  6. Broekmans FJ, Scheffer GJ, Bancsi LFJMM, Dorland M. Ovarian reserve tests in infertility practice and normal fertile women. 1998;30:205–14
  7. Hall JE. Endocrinology of the Menopause. Endocrinol Metab Clin NA [Internet]. 2015;44(3):485–96
  8. Rosendahl M, Ernst E, Rasmussen PE, Andersen CY. True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement. Fertil Steril [Internet]. 2010 Feb;93(3):995–8
  9. C Augood, K Duckitt AAT. Smoking and female infertility: a systematic review and. 1998;13(6):1532–9
  10. Bressler LH, Bernardi LA, De PJD. HHS Public Access. 2017;215(6):1–20
  11. Kee K, Flores M, Cedars MI, Pera RAR. Human Primordial Germ Cell Formation Is Diminished by Exposure to Environmental Toxicants Acting through the AHR Signaling Pathway. 2010;117(1):218–24
  12. Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem [Internet]. 2018 Dec;62:2–10. 13. te Velde E., Scheffer G., Dorland M, Broekmans F., Fauser BCJ. Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol [Internet]. 1998 Oct;145(1–2):67–73
  13. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014;20(3):370–85